Topic Archives: Jazz Pharmaceuticals (JAZZ)

Chris Wood at RiskHedge is selling one of his higher-end newsletters, Project 5X ($2,497 for the first year, 30-day refund period), by teasing that he will reveal “My #1 Play of the Psychedelic Medicine Revolution”… largely because, like many pundits, he believes that psychedelic drugs might follow the path worn by marijuana over the past […]

Comments

  • Spero (SPRO) does have a pipeline that is focused on multi-drug resistant (MDR) pathogens. They have several trials in p...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info